Brief: Novartis Completes Acquisition Of Tourmaline Bio
Oct 28 (Reuters) - Novartis AG NOVN.S: NOVARTIS COMPLETES ACQUISITION OF TOURMALINE BIO NOVARTIS AG - COMPLETES ACQUISITION OF TOURMALINE BIO NOVARTIS AG - WITH COMPLETION OF ACQUISITION, SHARES OF COMMON STOCK, PAR VALUE $0.0001 PER SHARE ( "SHARES") HAVE CEASED TRADING ON NASDAQ STOCK MARKET LLC Source text: ID:nGNE1q3Pvk Further company coverage: NOVN.S (Gdansk Newsroom) (((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600);))
Recent news on Tourmaline Bio
See all newsBrief: Novartis Completes Acquisition Of Tourmaline Bio
Brief: Novartis Announces Expiration Of Tourmaline Bio Tender Offer
Novartis nears deal to acquire Avidity Biosciences for over $70 per share, Bloomberg News reports (updated)
Brief: Novartis Announces Commencement Of Tender Offer To Acquire Tourmaline Bio
U.S. STOCKS ON THE MOVE-Potbelly, Joby, Talen Energy